RENAL-FAILURE IN THE NEONATE ASSOCIATED WITH IN-UTERO EXPOSURE TO NONSTEROIDAL ANTIINFLAMMATORY AGENTS

被引：104

作者：

KAPLAN, BS

RESTAINO, I

RAVAL, DS

GOTTLIEB, RP

BERNSTEIN, J

机构：

[1] Division of Nephrology, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, 19104, PA

[2] Division of Nephrology, The Children's Hospital-King's Daughter, Norfolk, 23507, VA

[3] Department of Pediatrics, University of Arizona, Tucson, Arizona

[4] Department of Pediatrics, Jefferson Medical College, Thomas Jefferson University, Philadelphia, 19107, PA

[5] Research Institute, William Beaumont Hospital, Royal Oak, 48073, MI

来源：

PEDIATRIC NEPHROLOGY | 1994年 / 8卷 / 06期

关键词：

RENAL FAILURE; FETUS AND NEONATE; INDOMETHACIN;

D O I：

10.1007/BF00869093

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

In utero exposure to non-steroidal anti-inflammatory agents (NSAIAs) can produce combinations of oligohydramnios, a bleeding diathesis, ileal perforation, premature closure of the ductus, and acute or chronic renal injury. NSAIAs induce renal dysgenesis in fetal monkeys and renal structural abnormalities in the developing human fetus. We report oligohydramnios and renal failure associated with in utero exposure to early, prolonged, high-dose indomethacin in four neonates, and to ibuprofen in one neonate. Four of the affected neonates were one of twins. In each set of twins, only one of the pair was affected. One set of twins was proven to be identical, whereas the other three sets seemed to be identical. It is possible that the histopathological findings of uncertain or incomplete tubular differentiation may be the result of a direct effect of NSAIAs on developing or ''immature'' tubules. Therefore, the advantages of NSAIAs as tocolytics need to be weighed against the complication of severe renal injury.

引用

页码：700 / 704

页数：5

共 22 条

[1]

Niebyl J.R., Witter F.R., Neonatal outcome after indomethacin treatment for preterm lobar, Am J Obstet Gynecol, 155, pp. 747-749, (1986)

[2]

Simeoni U., Messer J., Weisburd P., Haddad J., Willard D., Neonatal renal dysfunction and intrauterine exposure to prostaglandin synthesis inhibitors, Eur J Pediatr, 148, pp. 371-373, (1989)

[3]

Heuden A.D., Provoost A., Nauta J., Grose W., Oranje W.A., Wolff E.D., Sauer P.J., Renal functional impairment in preterm neonates related to intrauterine indomethacin exposure, Pediatr Res, 24, pp. 644-648, (1988)

[4]

Dudley D.K., Hardie M.J., Fetal and neonatal effects of indomethacin used as a tocolytic agent, Am J Obstet Gynecol, 151, pp. 181-184, (1985)

[5]

Vanhaesebrouck P., Thiery M., Leroy J.G., Govaert P., de Praeter C., Coppens M., Cuvelier C., Dhont M., Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin, The Journal of Pediatrics, 113, pp. 738-743, (1988)

[6]

Restaino I., Kaplan B.S., Kaplan P., Rosenberg H., Witzleben C., Roberts N., Renal dysgenesis in a monozygotic twin. Association with in utero exposure to indomethacin, Am J Med Genet, 39, pp. 252-257, (1991)

[7]

Gubler M.C., vd Heijden A.J., Carlus C., Lacoste M., Persistent anuria in 6 neonates exposed to indomethacin (ID) during pregnancy, J Am Soc Nephrol, 2, (1991)

[8]

Gloor J.M., Muchant D.G., Norling L.L., Prenatal maternal indomethacin use resulting in prolonged neonatal renal insufficiency, J Perinatol, 13, pp. 425-427, (1993)

[9]

Rose N., Kaplan P., Scott S., Kousoulis A., Librizzi R., The prenatal presentation of congenital chloride diarrhea, Am J Perinatol, 9, pp. 398-400, (1992)

[10]

Allanson J.E., Pantzar J.T., MacLeod P.M., Possible new autosomal recessive syndrome with unusual renal histopathological changes, Am J Med Genet, 16, pp. 57-60, (1983)

← 1 2 3 →